CELL AND GENE THERAPY WILL BE THE KEY DEVELOPMENT DIRECTION OF BEIJING'S PHARMACEUTICAL AND HEALTH INDUSTRY
THE DEVELOPMENT MOMENTUM OF CELL THERAPY IN CHINA IS STRONG, WITH 14 APPROVED CLINICAL PRODUCTS AND 24 NEWLY ACCEPTED PRODUCTS IN THE FIRST QUARTER
THE INDEPENDENT RESEARCH AND DEVELOPMENT INNOVATION AND INDUSTRIALIZATION OF BIOTECHNOLOGY AND BIG HEALTH INDUSTRIES IN BEIJING ECONOMIC-TECHNOLOGICAL DEVELOPMENT AREA "DOUBLE ACCELERATION"
Page up
1
2
3
Page down